STOCKWATCH
·
Pharmaceuticals
Quarterly Result8 May 2026, 08:41 pm

Bajaj Healthcare: FY26 Revenue ₹61,103.14 Lakhs

AI Summary

Bajaj Healthcare Ltd's board approved the audited standalone financial results for the quarter and year ended March 31, 2026. The company reported revenue from operations of ₹61,103.14 lakhs for FY26. A final dividend of 30% (₹1.50 per share) was recommended, subject to shareholder approval. M/s. JCR & Co. LLP were appointed as Internal Auditors for FY27, and M/s. V.J. Talati & Co. re-appointed as Cost Auditors for FY27.

Key Highlights

  • Bajaj Healthcare's FY26 revenue from operations reached ₹61,103.14 lakhs.
  • A final dividend of ₹1.50 per share (30% of face value) is recommended for FY26.
  • M/s. JCR & Co. LLP appointed as Internal Auditors for FY27.
  • M/s. V.J. Talati & Co. re-appointed as Cost Auditors for FY27.
  • Audited standalone financial results for the quarter and year ended March 31, 2026, were approved.
BAJAJHCARE
Pharmaceuticals
Bajaj Healthcare Ltd

Price Impact